Veronika is a co-founder and Chief Executive Officer of S-Biomedic. On top of her education in management and entrepreneurship Veronika is inspired by scientific research and its social impact. Veronika has gained multiple years of experience in project and quality management, business development and planning in various industries including biotech and healthcare.
Bernhard has completed his PhD in synthetic biology, working together in collaboration with pharmaceutical industry on designing bacteria as a living pill. He is a scientific co-founder of S-Biomedic and is leading the research and product development. His passion is the complex interplay of the bacterial community living in and on us. He is fascinated by the unused potential of the active compounds naturally produced right on our skin everyday.
Marc is a scientific co-founder and non-executive director of S-Biomedic. He is a Wyss Technology Development Fellow at the Wyss Institute under the mentorship of mentor: George Church, Harvard Medical School. His research interests are centered in synthetic biology, and in biological technology development.
Carlos Gallardo has over 15 years of experience in the pharmaceutical industry in areas such as licensing, business development and country management. His expertise lies in negotiating strategic company and product acquisitions and investments.
Prof. Dr. Sven Quist
Prof. Dr. Dr. Sven Quist focuses on research in pharmacodynamics of inflammatory medication and drug metabolism, systemic and topical dermatotherapy and magistral formulations. Prof. Quist has experience in leading several pharmaceutical studies on different infectious skin diseases. Additionally he is qualified pharmacist and registered medical pharmacist.
Prof. Luis Serrano
Prof. Luis Serrano was previously active as head of the EMBL Structural & Computational Biology Program at the European Molecular Biology Institute in Heidelberg. Since 2011 he is the director of Center for Genomic Regulation (CRG). His group is a leader in Europe in the field of system and synthetic biology. He has authored more than 270 scientific publications and 20 patents.
Prof. Toni Gabaldon
As ICREA Research Professor Toni Gabaldon focuses on comparative genomics and phylogenomics to study the origin, evolution and function of complex biological systems. He has more than 290 scientific publications in the areas of genomics, microbiology and bioinformatics.
CEO of Vedanta and venture partner at PureTech